Floatz logo

Parsaclisib

Parsaclisib

Fudan UniversitySmall moleculePhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Parsaclisib cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Fudan University
Phase 1/2CCC
PREDNISONE TABLETS
Fudan University
Phase 1/2CCC
Inno-206
Fudan University
Phase 1/2CCC
(+)-VINCRISTINE
Fudan University
Phase 1/2CCC

Same molecule, other indications

Parsaclisib is also rated in:

follicular lymphomaDormant
B
Indicative ·
60 / 100
View asset →
marginal zone lymphomaDormant
B
Indicative ·
60 / 100
View asset →
lymphomaDormant
B
Indicative ·
58 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →